Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea
· Delayed Price · Currency is KRW 3,675.00
-75.00 (-2.00%)
Last updated: Aug 12, 2025
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 304.79 billion as of August 14, 2025. Its market cap has increased by 10.01% in one year.
Market Cap
304.79B
Enterprise Value
385.56B
Revenue
6.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,675.00
Market Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 304.79B, a decrease of -50.30%. That is a compound annual growth rate of -14.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 291.18B | -26.11% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 467.88T |
| SK hynix | 190.88T |
| LG Energy Solution | 92.20T |
| Samsung Biologics | 73.52T |
| Hyundai Motor Company | 47.53T |
| Hanwha Aerospace | 45.17T |
| HD Hyundai Heavy Industries | 42.34T |
| Doosan Enerbility | 41.95T |